San Francisco, CA, United States of America

Daniel V Santi

USPTO Granted Patents = 61 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 16)

Average Co-Inventor Count = 2.8

ph-index = 15

Forward Citations = 1,061(Granted Patents)

Forward Citations (Not Self Cited) = 1,015(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

29 out of 110

Kosan Biosciences Incorporated

University of California

Bristol-myers Squibb Compnay

patents

6. 3 out of 832,843

Other

patents

Years Active: 1991-2025

Loading Chart...

Areas of Expertise:

DNA Damage Response

Cancer Treatment

Biodegradable Hydrogels

Controlled Drug Release

Polyketide Synthase

Recombinant DNA Constructs

Synthetic Discodermolide

Motilide Compounds

Prodrugs

Benzoquinone Ansamycins

Peptide Libraries

Biopolymer Synthesis

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12472261 - Conjugated inhibitors of DNA damage response (2025-11-18),

2. 11730836 - Synergistic cancer treatment (2023-08-22),

3. 11454861 - Hydrogels with biodegradable crosslinking (2022-09-27),

4. 11181803 - Hydrogels with biodegradable crosslinking (2021-11-23),

5. 11179470 - Hydrogels with biodegradable crosslinking (2021-11-23),

6. 10413594 - Conjugates of somatostatin analogues (2019-09-17),

7. 10398779 - Hydrogels with biodegradable crosslinking (2019-09-03),

8. 10086049 - Conjugates of somatostatin analogues (2018-10-02),

9. 9649385 - Hydrogels with biodegradable crosslinking (2017-05-16),

10. 9387254 - Prodrugs and drug-macromolecule conjugates having controlled drug release rates (2016-07-12),

11. 8946405 - Controlled release from solid supports (2015-02-03),

12. 8754190 - Controlled release from macromolecular conjugates (2014-06-17),

13. 8703907 - Controlled drug release from dendrimers (2014-04-22),

14. 8680315 - Prodrugs and drug-macromolecule conjugates having controlled drug release rates (2014-03-25),

15. 8003687 - Esters of compounds in the leptomycin family (2011-08-23),

Title: The Innovative Journey of Daniel V Santi

Introduction: Daniel V Santi, a visionary inventor based in San Francisco, CA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents: Daniel V Santi's latest patents include a cutting-edge wearable technology device that revolutionizes the healthcare industry by monitoring vital signs in real-time.

Career Highlights: With a career spanning over two decades, Daniel V Santi has established himself as a pioneer in the tech world, holding multiple patents in various sectors such as artificial intelligence, biotechnology, and renewable energy.

Collaborations: Throughout his career, Daniel V Santi has collaborated with leading research institutions, universities, and tech companies to bring his innovative ideas to life. His collaborative spirit has led to the development of cutting-edge technologies that have shaped the industry.

Conclusion: Daniel V Santi's passion for innovation and relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His contributions continue to inspire future generations of inventors and shape the landscape of innovation.

This text is generated by artificial intelligence and may not be accurate.